Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells

Cancer Research

Volumn 63, Issue 7, 2003, Pages 1515-1519

  Wu, Hao ^a   Hait, William N ^a   Yang, Jin Ming ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; DOXORUBICIN; GLYCOPROTEIN P; HYDROXYUREA; PACLITAXEL; RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VINBLASTINE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER RESISTANCE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG SENSITIVITY; GENE; GENE EXPRESSION; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MDR1 GENE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; HUMANS; P-GLYCOPROTEIN; PACLITAXEL; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0037380839     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ling, V. Multidrug resistance and P-glycoprotein expression. Ann. N. Y. Acad. Sci., 507: 7-8, 1987.
2. Roninson, I. B., Chin, J. E., Choi, K. G., Gros, P., Housman, D. E., Fojo, A., Shen, D. W., Gottesman, M. M., and Pastan, I. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc. Natl. Acad. Sci. USA, 83: 4538-4542, 1986.
3. Ford, J. M., and Hait, W. N. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev., 42: 155-199, 1990.
4. Yahanda, A. M., Adler, K. M., Fisher, G. M., Brophy, N. A., Halsy, J., Hardy, R. I., Gosland, M. P., Lum, B. L., and Sikic, B. I. Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance. J. Clin. Oncol., 10: 1624-1634, 1992.
5. Dalton, W. S., Grogan, T. M., Meltzer. P. S., Scheper, R. J., Durie, B. G. M., Taylor, C. W., Miller, T. P., and Salmon, S. E. Drug-resistance in multiple myeloma and nonHodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J. Clin. Oncol., 7: 415-424, 1989.
6. Sonneveld, P., Durie, B. G, M., Lokhurst, H. M., Marie, J. P., Solbu, B., Suciu, S., Zittoun, R., Lowenberg, B., and Nooter, K. Modulation of multidrug-resistant multiple myeloma by cyclosporin. Lancet, 340: 255-259, 1992.
7. Halt, W. N., Stein, J. M., Koletsky, A. J., Harding, M. W., and Handschmnacher, R. E. Activity of cyclosporin A and a non-immunosuppressive cyclosporin against multidrug resistant leukemic cell lines. Cancer Commun., 1: 35-43, 1989.
8. Hannon, G. J. RNA interference. Nature (Lond.), 418: 244-251, 2002.
9. Tuschl, T., Zamore, P. D., Lehmann, R., Bartel, D. P., and Sharp, P. A. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev., 13: 3191-3197, 1999.
10. Cohen, J. S., Lyon, R. C., Chen, C., Faustino, P. J., Batist, G., Shoemaker, M., Rubalcaba, E., and Cowan, K. H. Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy. Cancer Res., 46: 4087-4090, 1986.
11. Yu, G., Ahmad, S., Aquino, A., Fairchild, C. R., Trepel, J. B., Ohno, S., Suzuki, K., Tsuruo, T., Cowan, K. H., and Glazer, R. I. Transfection with protein kinase C α confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun., 3: 181-189, 1991.
12. Alaoui Jamali, M. A., Yin, M. B., Mazzoni, A., Bankusli, I., and Rustum, Y. M. Relationship between cytotoxicity, drug accumulation. DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933, Cancer Chemother Pharmacol., 25: 77-83, 1989.
13. Mi, Q., Cui, B., Silva, G. L., Lantvit, D., Lim, E., Chai, H., You, M., Hollingshead, M. G., Mayo, J. G., Kinghorn, A. D., and Pezzuto, J. M. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype. Cancer Res., 61: 4030-4037, 2001.
14. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA, 76: 4350-4354, 1979.
15. Yang, J. M., Sullivan, G. F., and Hait, W. N. Regulation of the function of P-glycoprotein by epidermal growth factor through phospholipase C. Biochem. Pharmacol., 53: 1597-604, 1997.
16. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (Lond.), 411: 494-498, 2001.
17. Jacque, J. M., Triques, K., and Stevenson, M. Modulation of HIV-1 replication by RNA interference. Nature (Lond.), 418: 435-438, 2002.
18. Novina, C. D., Murray, M. F., Dykxhoorn, D. M., Beresford, P. J., Riess, J., Lee, S. K., Collman, R. G., Lieberman, J., Shankar, P., and Sharp, P. A. siRNA-directed inhibition of HIV-1 infection. Nat. Med., 8: 681-686, 2002.
19. Cobum, G. A., and Cullen, B. R. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J. Virol., 76: 9225-9231, 2002.
20. Lee, N. S., Dohjima, T., Bauer, G., Li, H., Li, M. J., Ehsani, A., Salvaterra, P., and Rossi, J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol., 20: 500-505, 2002.
21. Xu, D., Ye, D., Fisher, M., and Juliano, R. L. Selective inhibition of P-glycoprotein expression in multidrug- resistant tumor cells by a designed transcriptional regulator. J. Pharmacol. Exp. Ther., 302: 963-971, 2002.
22. Mechetner, E. B., and Roninson, I. B. Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Proc. Natl. Acad. Sci. USA, 89: 5824-5828, 1992.
23. Astriab-Fisher, A., Sergueev, D. S., Fisher, M., Shaw, B. R., and Juliano, R. L. Antisense inhibition of P-glycoprotein expression using peptidc- oligonucleotide conjugates. Biochem. Pharmacol., 60: 83-90, 2000.
24. Yang, J. M., Vassil, A. D., and Hait, W. N. Activation of phospholipase C induces the expression of the multidrug resistance (MDRI) gene through the Raf-MAPK pathway. Mol. Pharmacol., 60: 674-680, 2001.
25. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., and Mello, C. C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (Lond.), 391: 806-811, 1998.
26. Muller, C., Laurent, G., and Ling, V. P-glycoprotein stability is affected by serum deprivation and high cell density in multidrug-resistant cells. J. Cell Physiol., 163: 538-544, 1995.
27. Wells, W. W., Rocque, P. A., Xu, D. P., Meyer, E. B., Charamella, L. J., and Dimitrov, N. V. Ascorbic acid and cell survival of adriamycin resistant and sensitive MCF-7 breast tumor cells. Free Radic. Biol. Med., 18: 699-708, 1995.
28. Sui, G., Soohoo, C., Affar el, B., Gay, F., Shi, Y., and Forrester, W. C. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA, 99: 5515-5520, 2002.
29. Paddison, P. J., Caudy, A. A., and Hannon, G. J. Stable suppression of gene expression by RNAi in mammalian cells. Proc. Natl. Acad. Sci. USA, 99: 1443-1448, 2002.
30. Miyagishi, M., and Taira, K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol., 20: 497-500, 2002.
31. Paul, C. P., Good, P. D., Winer, I., and Engelke, D. R. Effective expression of small interfering RNA in human cells. Nat. Biotechnol., 20: 505-508, 2002.
32. Lewis, D. L., Hagstrom, J. E., Loomis, A. G., Wolff, J. A., and Herweijer, H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet., 32: 107-108, 2002.
33. McCaffrey, A. P., Meuse, L., Pham, T. T., Conklin, D. S., Hannon, G. J., and Kay, M. A. RNA interference in adult mice. Nature (Lond.), 418: 38-39, 2002.